Ann: CE, FDA and CFDA Approval - Guangzhou Production Facility, page-178

https://www.asx.com.au/asxpdf/20171110/pdf/43p3v0h5x97rth.pdf

Has this requirement in the above announcement been finalised yet?

“G Medical advises that at this time, the Tier 1 partners of FCL have not yet formalised a definitive arrangement with FCL, and thus FCL have not yet established their ‘Letter of Credit’ (details of the Tier 1 partners and ‘Letter of Credit’ are outlined later in this release). On this basis, the Company cannot categorically state that the full anticipated revenues under the Agreement with FCL can be achieved, until such time as the above have been formalised.”